Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios — China, 2023−2024
China CDC Weekly · 2026 · 8 (21) · 653-658
DOI: 10.46234/ccdcw2026.106 ↗Kurz gefasst
Fachartikel in der Zeitschrift China CDC Weekly, 2026. Verfasst von Jingjuan Ren und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chi…. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention & Chinese Academy of Pr…
- School of Public Health, Peking University, Beijing, China.
- Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing, China.
- National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Tuberculosis, Public Health Clinical Center Affiliated to Shandong University, Jinan City, Shandong Province, China.
- Division Two of Pulmonary Diseases Department, Shenzhen Third People's Hospital, Shenzhen Clinical Research Center for Tuberculosis, National Clinical Research Center for Infectious Disease (Shenzhen), Southern Universi…
Zitieren
APA
Ren, J., Wang, N., Zhu, H., Nie, W., Sun, F., Xiong, Y., Fu, L., Luo, H., Cheng, S., Zhao, Y., & Huang, F. (2026). Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios — China, 2023−2024. China CDC Weekly, 8(21), 653-658. https://doi.org/10.46234/ccdcw2026.106
Vancouver
Ren J, Wang N, Zhu H, Nie W, Sun F, Xiong Y, et al. Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios — China, 2023−2024. China CDC Weekly. 2026;8(21):653-658. doi:10.46234/ccdcw2026.106
BibTeX
@article{Ren2026,
author = {Ren, Jingjuan and Wang, Ni and Zhu, He and Nie, Wenjuan and Sun, Feng and Xiong, Yu and Fu, Liang and Luo, Hui and Cheng, Shiming and Zhao, Yanlin and Huang, Fei},
title = {Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios — China, 2023−2024},
journal = {China CDC Weekly},
year = {2026},
volume = {8},
number = {21},
pages = {653--658},
doi = {10.46234/ccdcw2026.106}
}
EUVIMED